{"uid":"15ade838a2089739","name":"TEST-SPO-5000.01","historyId":"METTA-WAM-ISSUE-116:METTA-WAM-ISSUE-116#TEST-SPO-5000.01","time":{"start":1727514046000,"stop":1727514046138,"duration":138},"status":"passed","flaky":false,"newFailed":false,"newBroken":false,"newPassed":false,"retriesCount":0,"retriesStatusChange":false,"beforeStages":[],"testStage":{"steps":[{"name":"<![CDATA[","time":{},"steps":[],"attachments":[],"parameters":[],"shouldDisplayMessage":false,"stepsCount":0,"attachmentsCount":0,"hasContent":false,"attachmentStep":false},{"name":"<a href=\"https://trueagi-io.github.io/metta-wam/reports/tests_output/baseline-compat/tests/baseline_compat/anti-regression/issues/metta-wam-issue-116/test_spo_5000.metta.0_failed.html#METTA-WAM-ISSUE-116.TEST-SPO-5000.01\">Test Report</a>","time":{},"steps":[],"attachments":[],"parameters":[],"shouldDisplayMessage":false,"stepsCount":0,"attachmentsCount":0,"hasContent":false,"attachmentStep":false},{"name":"","time":{},"steps":[],"attachments":[],"parameters":[],"shouldDisplayMessage":false,"stepsCount":0,"attachmentsCount":0,"hasContent":false,"attachmentStep":false},{"name":"Assertion: (assertEqualToResult (match &hald5000 (Doxorubicin $p $o) (Doxorubicin $p $o)))","time":{},"steps":[],"attachments":[],"parameters":[],"shouldDisplayMessage":false,"stepsCount":0,"attachmentsCount":0,"hasContent":false,"attachmentStep":false},{"name":"Expected: ((Doxorubicin elevated Trastuzumab) (Doxorubicin associated MIR375) (Doxorubicin stratify Liposarcoma))","time":{},"steps":[],"attachments":[],"parameters":[],"shouldDisplayMessage":false,"stepsCount":0,"attachmentsCount":0,"hasContent":false,"attachmentStep":false},{"name":"Actual: ((Doxorubicin stratify Liposarcoma) (Doxorubicin associated MIR375) (Doxorubicin elevated Trastuzumab))","time":{},"steps":[],"attachments":[],"parameters":[],"shouldDisplayMessage":false,"stepsCount":0,"attachmentsCount":0,"hasContent":false,"attachmentStep":false},{"name":"]]>","time":{},"steps":[],"attachments":[],"parameters":[],"shouldDisplayMessage":false,"stepsCount":0,"attachmentsCount":0,"hasContent":false,"attachmentStep":false}],"attachments":[],"parameters":[],"shouldDisplayMessage":false,"stepsCount":7,"attachmentsCount":0,"hasContent":true,"attachmentStep":false},"afterStages":[],"labels":[{"name":"resultFormat","value":"junit"},{"name":"suite","value":"METTA-WAM-ISSUE-116"},{"name":"testClass","value":"METTA-WAM-ISSUE-116"},{"name":"package","value":"METTA-WAM-ISSUE-116"}],"parameters":[],"links":[],"hidden":false,"retry":false,"extra":{"severity":"normal","retries":[],"categories":[],"history":{"statistic":{"failed":0,"broken":0,"skipped":0,"passed":7,"unknown":0,"total":7},"items":[{"uid":"f8b09f12b3f567c7","reportUrl":"https://trueagi-io.github.io/metta-wam/ci/271//#testresult/f8b09f12b3f567c7","status":"passed","time":{"start":1727513882000,"stop":1727513882113,"duration":113}},{"uid":"a2a3b6a1deed9edb","reportUrl":"https://trueagi-io.github.io/metta-wam/ci/270//#testresult/a2a3b6a1deed9edb","status":"passed","time":{"start":1727489952000,"stop":1727489952132,"duration":132}},{"uid":"f841f1bff636c7e3","reportUrl":"https://trueagi-io.github.io/metta-wam/ci/268//#testresult/f841f1bff636c7e3","status":"passed","time":{"start":1727481371000,"stop":1727481371134,"duration":134}},{"uid":"971e56a8011c9dc2","reportUrl":"https://trueagi-io.github.io/metta-wam/ci/267//#testresult/971e56a8011c9dc2","status":"passed","time":{"start":1727480143000,"stop":1727480143160,"duration":160}},{"uid":"c62034443d9f1e6b","reportUrl":"https://trueagi-io.github.io/metta-wam/ci/266//#testresult/c62034443d9f1e6b","status":"passed","time":{"start":1727480011000,"stop":1727480011140,"duration":140}},{"uid":"71b0df181cc16d46","reportUrl":"https://trueagi-io.github.io/metta-wam/ci/265//#testresult/71b0df181cc16d46","status":"passed","time":{"start":1727475220000,"stop":1727475220166,"duration":166}}]},"tags":[]},"source":"15ade838a2089739.json","parameterValues":[]}